Cooper Companies (NASDAQ:COO – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 3.640-3.670 for the period, compared to the consensus earnings per share estimate of 3.570. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion. Cooper Companies also updated its Q4 guidance to $0.98-1.01 EPS.
Cooper Companies Trading Up 0.3 %
NASDAQ:COO opened at $106.00 on Friday. The stock has a market cap of $21.11 billion, a price-to-earnings ratio of 62.19, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98. Cooper Companies has a one year low of $75.93 and a one year high of $106.69. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The business’s 50-day simple moving average is $91.25 and its 200 day simple moving average is $94.12.
Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. During the same quarter in the previous year, the firm earned $0.84 earnings per share. The business’s revenue was up 7.8% compared to the same quarter last year. As a group, sell-side analysts predict that Cooper Companies will post 3.57 earnings per share for the current fiscal year.
Analyst Ratings Changes
View Our Latest Report on Cooper Companies
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles
- Five stocks we like better than Cooper Companies
- About the Markup Calculator
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
- The Significance of Brokerage Rankings in Stock Selection
- 3M’s Turnaround Story Will Continue This Year
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.